Cargando…

Immunogenicity of plant‐produced porcine circovirus‐like particles in mice

Porcine circovirus type 2 (PCV‐2) is the main causative agent associated with a group of diseases collectively known as porcine circovirus‐associated disease (PCAD). There is a significant economic strain on the global swine industry due to PCAD and the production of commercial PCV‐2 vaccines is exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunter, Cornelius J., Regnard, Guy L., Rybicki, Edward P., Hitzeroth, Inga I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686138/
https://www.ncbi.nlm.nih.gov/pubmed/30791210
http://dx.doi.org/10.1111/pbi.13097
_version_ 1783442502884261888
author Gunter, Cornelius J.
Regnard, Guy L.
Rybicki, Edward P.
Hitzeroth, Inga I.
author_facet Gunter, Cornelius J.
Regnard, Guy L.
Rybicki, Edward P.
Hitzeroth, Inga I.
author_sort Gunter, Cornelius J.
collection PubMed
description Porcine circovirus type 2 (PCV‐2) is the main causative agent associated with a group of diseases collectively known as porcine circovirus‐associated disease (PCAD). There is a significant economic strain on the global swine industry due to PCAD and the production of commercial PCV‐2 vaccines is expensive. Plant expression systems are increasingly regarded as a viable technology to produce recombinant proteins for use as pharmaceutical agents and vaccines. However, successful production and purification of PCV‐2 capsid protein (CP) from plants is an essential first step towards the goal of a plant‐produced PCV‐2 vaccine candidate. In this study, the PCV‐2 CP was transiently expressed in Nicotiana benthamiana plants via agroinfiltration and PCV‐2 CP was successfully purified using sucrose gradient ultracentrifugation. The CP self‐assembled into virus‐like particles (VLPs) resembling native virions and up to 6.5 mg of VLPs could be purified from 1 kg of leaf wet weight. Mice immunized with the plant‐produced PCV‐2 VLPs elicited specific antibody responses to PCV‐2 CP. This is the first report describing the expression of PCV‐2 CP in plants, the confirmation of its assembly into VLPs and the demonstration of their use to elicit a strong immune response in a mammalian model.
format Online
Article
Text
id pubmed-6686138
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66861382019-08-12 Immunogenicity of plant‐produced porcine circovirus‐like particles in mice Gunter, Cornelius J. Regnard, Guy L. Rybicki, Edward P. Hitzeroth, Inga I. Plant Biotechnol J Research Articles Porcine circovirus type 2 (PCV‐2) is the main causative agent associated with a group of diseases collectively known as porcine circovirus‐associated disease (PCAD). There is a significant economic strain on the global swine industry due to PCAD and the production of commercial PCV‐2 vaccines is expensive. Plant expression systems are increasingly regarded as a viable technology to produce recombinant proteins for use as pharmaceutical agents and vaccines. However, successful production and purification of PCV‐2 capsid protein (CP) from plants is an essential first step towards the goal of a plant‐produced PCV‐2 vaccine candidate. In this study, the PCV‐2 CP was transiently expressed in Nicotiana benthamiana plants via agroinfiltration and PCV‐2 CP was successfully purified using sucrose gradient ultracentrifugation. The CP self‐assembled into virus‐like particles (VLPs) resembling native virions and up to 6.5 mg of VLPs could be purified from 1 kg of leaf wet weight. Mice immunized with the plant‐produced PCV‐2 VLPs elicited specific antibody responses to PCV‐2 CP. This is the first report describing the expression of PCV‐2 CP in plants, the confirmation of its assembly into VLPs and the demonstration of their use to elicit a strong immune response in a mammalian model. John Wiley and Sons Inc. 2019-03-10 2019-09 /pmc/articles/PMC6686138/ /pubmed/30791210 http://dx.doi.org/10.1111/pbi.13097 Text en © 2019 The Authors. Plant Biotechnology Journal published by Society for Experimental Biology and The Association of Applied Biologists and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Gunter, Cornelius J.
Regnard, Guy L.
Rybicki, Edward P.
Hitzeroth, Inga I.
Immunogenicity of plant‐produced porcine circovirus‐like particles in mice
title Immunogenicity of plant‐produced porcine circovirus‐like particles in mice
title_full Immunogenicity of plant‐produced porcine circovirus‐like particles in mice
title_fullStr Immunogenicity of plant‐produced porcine circovirus‐like particles in mice
title_full_unstemmed Immunogenicity of plant‐produced porcine circovirus‐like particles in mice
title_short Immunogenicity of plant‐produced porcine circovirus‐like particles in mice
title_sort immunogenicity of plant‐produced porcine circovirus‐like particles in mice
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686138/
https://www.ncbi.nlm.nih.gov/pubmed/30791210
http://dx.doi.org/10.1111/pbi.13097
work_keys_str_mv AT guntercorneliusj immunogenicityofplantproducedporcinecircoviruslikeparticlesinmice
AT regnardguyl immunogenicityofplantproducedporcinecircoviruslikeparticlesinmice
AT rybickiedwardp immunogenicityofplantproducedporcinecircoviruslikeparticlesinmice
AT hitzerothingai immunogenicityofplantproducedporcinecircoviruslikeparticlesinmice